Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Chudan Chi

1PUBLICATIONS

12CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Mar 22, 2025

Cuproptosis inhibits tumor progression and enhances cisplatin toxicity in ovarian cancer.

Qiaojian Zou, Yili Chen, Duo Liu

Pageof 1

Frequent Collaborators

1 joint publications

Qiaojian Zou

1 joint publications

Yili Chen

1 joint publications

Duo Liu

1 joint publications

Qiqiao Du

1 joint publications

Chunyu Zhang

1 joint publications

Qiuwen Mai

1 joint publications

Xiaojun Wang

1 joint publications

Xiaoying Lin

1 joint publications

Qianrun Chen

1 joint publications

Mengxun Wei

Frequent Collaborators

1 joint publications

Qiaojian Zou

1 joint publications

Yili Chen

1 joint publications

Duo Liu

1 joint publications

Qiqiao Du

Top Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

See more related videos

Top Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

See more related videos